In San Diego, scientists at GemPharmatech Co. Ltd. newly expanded U.S. campus are deep in the lab, advancing drug discovery. Since its founding in Nanjing in 2017, GemPharmatech has built the world’s largest genetic mouse model repository—with over 22,000 models. This U.S. hub now offers global clients not just models, but turnkey preclinical efficacy solutions.

Across the globe in Toronto, Geneseeq Technology is anchoring its North American strategy, exporting advanced diagnostic kits and expanding its international reach.

And in Southeast Asia, Micro-Tech Endoscopy just broke ground on its new Thailand Manufacturing Center, embedding “Smart Made in Nanjing” into the region’s medtech supply chain.

Global footprints like these are more than business expansion—they are markers of a city’s innovation influence. And as more Nanjing-based companies go global, they carry with them the DNA of a city built on R&D, resilience, and results.